Biocon Ltd has named Anupam Jindal as the new Chief Financial Officer (CFO) and he will also be part of the executive leadership team.
Jindal will report to the Chief Executive Officer and Managing Director Siddharth Mittal. “We are pleased to have Jindal join us at this crucial phase of our growth as we expand our portfolio and enter new geographies to address patient needs for affordable, high-quality medicines,” said Mittal.
“With his proven track record of steering high-growth companies, he will play a key role in helping deliver on our business goals,” he added.
Jindal, a chartered accountant from the Institute of Chartered Accountants of India and a company secretary from the Institute of Company Secretaries of India, comes with a rich background. Before Biocon, he worked with the Vedanta Group of companies for 22 years where he held the position of Group Chief Financial Officer at Sterlite Technologies since 2006.
In his previous role, he has coontibuted in growing the company’s revenue through organic capacity expansion and acquisitions in India and abroad. He was also instrumental in driving several strategic initiatives like the inception and growth of new business verticals. Now in his new role how he uses his experize and knowledge to spearhead, biopharmaceutical company, Biocon upto new heights is to look forward to.